Sarepta Therapeutics Gross Margin 2010-2025 | SRPT

Sarepta Therapeutics gross margin for the quarter ending March 31, 2025 was 81.77%.

  • Sarepta Therapeutics average gross margin for 2024 was 86.42%, a 0.33% decline from 2023.
  • Sarepta Therapeutics average gross margin for 2023 was 86.71%, a 1.83% decline from 2022.
  • Sarepta Therapeutics average gross margin for 2022 was 85.15%, a 2% increase from 2021.

Gross margin can be defined as a company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage.

Sarepta Therapeutics Gross Margin 2010-2025 | SRPT

  • Sarepta Therapeutics average gross margin for 2024 was 86.42%, a 0.33% decline from 2023.
  • Sarepta Therapeutics average gross margin for 2023 was 86.71%, a 1.83% decline from 2022.
  • Sarepta Therapeutics average gross margin for 2022 was 85.15%, a 2% increase from 2021.

Gross margin can be defined as a company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage.